Pfizer’s PARP inhibitor Talzenna has become the first targeted treatment for HER2-negative locally advanced or metastatic breast cancer with BRCA1/2 mutations to be recommended by NICE for ...

Brand naming deserves more careful thought and strategy. After all, your business name will likely stick around for a long time - Pick a good one! What's in a name? A lot, actually. The right brand ...

Something that does the talking so she can use her words for the boardroom. We’ve looked into high-end purse brands that feel and smell like luxury and not all need to have a major price tag ...

TALZENNA in combination with XTANDI was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with HRR gene-mutated mCRPC in June 2023.

Cuup was founded on the basis that the majority of women wear the wrong bra size, largely thanks to old-school lingerie brands that confined women to a small and unrealistic range of fits.

Still, it remains an iconic brand with some of the most cutting edge TVs out there. It pushes the envelope with its QD-OLED technology, whilst offering some of the brightest and boldest QLED TVs.

Key Pfizer presentations at ASCO GU include the detailed overall survival (OS) results from the Phase 3 TALAPRO-2 trial with TALZENNA ® (talazoparib) plus XTANDI ® (enzalutamide) in patients ...

Today, Pfizer said that its phase 3 TALAPRO 2 trial of PARP drug Talzenna (talazoparib) in combination with its Astellas-partnered anti-androgen therapy Xtandi (enzalutamide) reduced radiographic ...